Devon Energy Corporation (DVN) has filed an 8-K report detailing the results of its 2026 Annual Meeting of Stockholders held on June 30, 2026. Key outcomes include the election of all eleven board nominees, the re-appointment of KPMG LLP as the independent auditor, and the approval of the executive compensation package. The report indicates corporate stability due to the lack of surprises or significant changes in governance, auditing, or executive compensation, suggesting no immediate price-moving catalysts for DVN shares from this filing.

CareDx (NASDAQ:CDNA) has completed the sale of its Lab Products business to Eurobio Scientific for $171.2 million in cash. This divestiture allows CareDx to focus on its U.S. precision medicine testing services and patient and digital solutions, aiming to simplify its operating model and support investments in high-growth areas like specialty oncology. The company's stock has seen positive market response, trading near its 52-week high and surging 55% year-to-date, though analysts suggest it may be overvalued at current levels.

CIBC has introduced market-linked Senior Global Medium-Term Notes tied to the Russell 2000 Index, offering a 200% upside participation rate but with a maximum return of at least 25.65%. These notes feature a 10% principal buffer, meaning 1-for-1 downside exposure only applies if the index falls more than 10% below the starting level, with potential losses up to 90% of the principal. The securities do not pay periodic interest, are unsecured obligations of CIBC, and are designed to be held to maturity due to uncertain secondary-market liquidity.

Camden National Corporation (NASDAQ: CAC) announced that its board of directors has declared a quarterly dividend of $0.42 per share. This payout results in an annualized dividend yield of 3.11% based on the June 29, 2026 closing price of $53.96 per share. The dividend is payable on July 31, 2026, to shareholders of record as of July 15, 2026.

This article provides the "Price to book forward" for Corebridge Financial, Inc. (SWB:AS5), listed on the Stuttgart Stock Exchange. The content is primarily a data point for investors interested in the company's financial metrics.

This article announces the filing of Form 144 for Concentra Group Holdings Parent for June 30. It is a brief report from Investing.com, providing basic information without further details within the main text.

This article from Investing.com reports the filing of a Form 4 by Lionheart Holdings for June 30. Form 4s are filed with the SEC by company insiders and are used to disclose changes in ownership of the company's securities. The brief article provides no further details on the specific contents of this Form 4.

Realty Income Corporation has launched an offering of €600 million aggregate principal amount of 3.625% senior notes due July 30, 2032. The notes will accrue interest from July 7, 2026, payable annually, and the net proceeds will be used for general corporate purposes, including debt repayment, property acquisitions, and hedging. The offering includes provisions for listing on the NYSE and details on debt covenants, which the company currently meets with a total debt of 41.4% of adjusted total assets and total unencumbered assets of 242.5% of unsecured debt as of March 31, 2026.

Carmen Bozic, EVP and Chief Medical Officer at Vertex Pharmaceuticals, sold 596 shares of company stock for $287,570 on June 26, 2026. This transaction was executed under a Rule 10b5-1 trading plan established in November 2025. Vertex Pharmaceuticals is actively working on new treatments and expanding its market reach, with recent developments including an FDA acceptance for povetacicept and a reimbursement agreement in Germany for CASGEVY.

Cronos Group Inc. has appointed ATB Capital Markets Corp. (ATB Cormark) as its new broker for share repurchases in Canada, replacing Virtu Canada Corp. This change relates to its previously announced share repurchase program on the TSX and other Canadian trading systems. Cronos is a global cannabis company focused on innovation and building an iconic brand portfolio.